Safety Alerts & Recalls

What does this mean?

This recall for CREON (pancrelipase) Delayed Release Capsules, 6000 USP units was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take CREON (pancrelipase) Delayed Release Capsules, 6000 USP units and are concerned, you should speak to your doctor or other healthcare professional.

Abbott Laboratories Recalls Several Lots of CREON (pancrelipase) Delayed Release Capsules, 6000 USP units

Abbott Laboratories and Solvay Pharmaceuticals is recalling several lots of CREON (pancrelipase) Delayed Release Capsules, 6000 USP units. Lot numbers 44840, 45114, and 45398 are being recalled because routine testing found that the amount of active ingredient was too low in several samples from these lots.

CREON contains the active ingredient pancrelipase and is commonly used in helping digestion of fats, proteins and sugars in certain conditions such as cystic fibrosis. Pancrelipase is also sold under other brand names. This recall alert only applies to the select lots of CREON (pancrelipase) Delayed Release Capsules, 6000 USP units. No other pancrelipase products were involved in this recall.

To view the FDA notice about this recall, please visit: more information here

Source: FDA
Publication Date: 2011-04-25
Last Updated: 2011-05-02

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.